We could not find any results for:
Make sure your spelling is correct or try broadening your search.
0000887247 false --12-31 0000887247 2023-09-06 2023-09-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED...
SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the company changed its name to DMK...
0000887247 false 0000887247 2023-08-30 2023-08-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares ...
0000887247 false 0000887247 2023-08-23 2023-08-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares ...
0000887247 false 0000887247 2023-08-21 2023-08-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares ...
SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Β Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced financial results for the second...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SEC FILE NUMBER 000-26372 FORM 12b...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ...
SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the closing of its public offering...
0000887247 false 0000887247 2023-08-01 2023-08-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | -7.617937 | -90.7653639938 | 8.393 | 9.45 | 0.75 | 1786411 | 3.08537163 | CS |
156 | -63.554937 | -98.795176434 | 64.33 | 103.6 | 0.75 | 2762324 | 53.61608219 | CS |
260 | -142.024937 | -99.4572387955 | 142.8 | 171.5 | 0.75 | 3496396 | 66.57037442 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions